Earlier this week the Second Circuit affirmed a lower court’s holding which found that drug manufacturer Pfizer Inc.’s practice of providing copay assistance to Medicare beneficiaries violated the Federal Anti-Kickback Statute (“AKS”).... Read More
Last week, the House of Representatives passed an act to extend Medicare telehealth flexibilities after the conclusion of the Public Health Emergency (“PHE”). The “Advancing Telehealth Beyond COVID–19 Act of 2022” (“Act”) aims to... Read More
The Office for Civil Rights (OCR) recently announced the resolution of eleven investigations in its Health Insurance Portability and Accountability Act (HIPAA) Right of Access Initiative, bringing the total number of enforcement actions to... Read More
As previously reported, Frier Levitt filed suit against the New York Department of Health and the New York State Department of Education on behalf of an independent New York oncology practice in an effort to void the State’s new and legally... Read More
The Department of Justice ("DOJ") indicted a North Carolina physician assistant last month on criminal charges in a genetic testing scheme that resulted in the submission of more than $10 million in fraudulent claims to Medicare. The indictment... Read More
During the 2021 fiscal year, The U.S. Department of Justice (DOJ) recovered $5.6 billion in civil settlements and judgments involving fraud and violations of the False Claims Act; a record-breaking $5 billion of this recovery was derived from... Read More
On July 20, 2022, the Office of Inspector General (OIG) issued a Special Fraud Alert warning practitioners to exercise caution when entering into certain telehealth arrangements. The Alert references the many recent investigations of telemedicine... Read More
On July 14, 2022, the United States Department of Justice (DOJ) announced that OPKO Health, Inc. (“OPKO”) and its subsidiary, BioReference Health LLC (“BioReference”), agreed to pay $9.85 million to resolve claims under the Federal False... Read More
The Department of Justice (DOJ)’s enforcement efforts aimed at speaker programs have not slowed since the DOJ filed criminal and civil actions against Insys, its executives, and scores of physicians relating to the off-label promotion of Subsys,... Read More
Anthony Mahajan, Frier Levitt Partner and Chair of the White-Collar Defense and Government Investigations practice, recently published an article in Applied Clinical Trials, titled “Are You a Victim of Clinical Trial Fraud? If So, What Are Your... Read More
